Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyoxylate reductase 1 homolog (GLYR1) is a chromatin-associated nuclear protein functioning primarily as a nucleosome-destabilizing factor, a chromatin-protein adaptor, and a histone-binding protein[1][6][7]. It is recruited to active genes and regulates transcription through its interactions with chromatin, facilitating transcriptional activation and elongation processes[7][1][6]. GLYR1 positively regulates histone acetylation, participating in epigenetic regulation[3][7]. The protein has also been described as a putative oxidoreductase based on sequence homology, but its main characterized role in mammalian cells is transcriptional regulation linked to chromatin structure and accessibility rather than classic metabolic enzyme activity[1][6][7]. Disease associations include roles in cancer and potentially in other chromatin or transcriptional disorders, but specific therapeutic drug interactions or biomarker roles have not been clearly established in current databases[6][3].
Modulation of chromatin structure to regulate transcription Epigenetic modification reader/adaptor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyoxylate reductase 1 homolog (GLYR1).